← All stocks

Starling Oncology, Inc.

STLN No buying or selling
CIK 0001799191 #2884 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

17 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Chernett Jorey
10% owner
10,660,858
$69.43M
+8.0%
M33 Growth I L.P.
Director
5,444,207
$35.46M
−64.3%
BARASCH RICHARD A
Director
4,571,022
$29.77M
+101.2%
Virnich Daniel
Chief Executive Officer
2,337,166
$15.22M
+3.5%
Carter Robert Ross
Chief Financial Officer
649,975
$4.23M
−3.4%
Pacala Mark L
Director
511,852
$3.33M
+42.2%
Hively Brad
Director
411,976
$2.68M
−45.2%
Ling Gabriel
Director
333,539
$2.17M
+383.0%
McGeorge Anne
Director
332,535
$2.17M
+161.1%
Johnson Karen Marie
Director
319,410
$2.08M
+177.3%
Podnos Yale
Chief Medical Officer
259,527
$1.69M
+148.7%
Castle Jeremy
Chief Operating Officer
247,031
$1.61M
+199.6%
Kaushal Mohit
Director
205,716
$1.34M
+69.7%
England Kristin
Chief Administrative Officer
153,780
$1.00M
Langsam Jeffrey
Chief Clinical Officer
127,650
$831.33K
STOLPER MARK
Director
56,957
$370.94K
TZOUMAKAS KIMBERLY JO
Director
46,301
$301.54K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 17 Mar 2020